Additionally, Ki-67 staining confirmed that proliferation of BPH-1 and WPMY-1 cells supplemented with testosterone was significantly reduced by 5-HT treatment (Fig. 4a and c), while PNT1A cells proliferation was not affected (Fig. 4b). This evidence concerns the gene MKI67 and benign prostatic hyperplasia.